Krystal Biotech reported revenue of $119.22M and net income of $54.77M for the quarter ended Jun 2026, up 24.1% year over year. This income statement covers 40 quarters of results from Sep 2016 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | ||||||||||||||||||||||||||||||||||||||||
| Revenue | 8.56M | 42.14M | 45.30M | 70.30M | 83.84M | 91.11M | 88.20M | 96.04M | 97.80M | 107.11M | 116.40M | 119.22M | ||||||||||||||||||||||||||||
| Cost of RevenueCost of Rev | 0.22M | 2.87M | 2.42M | 6.01M | 6.68M | 4.95M | 5.03M | 7.17M | 4.26M | 6.59M | 6.32M | 6.44M | ||||||||||||||||||||||||||||
| Gross Profit | 8.33M | 39.27M | 42.88M | 64.29M | 77.16M | 86.17M | 83.17M | 88.88M | 93.54M | 100.51M | 110.08M | 112.78M | ||||||||||||||||||||||||||||
| Operating items | ||||||||||||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 6.08M | 9.01M | 9.31M | 10.89M | 11.52M | 10.74M | 12.29M | 12.14M | 10.63M | 11.37M | 10.96M | 15.58M | 13.51M | 13.53M | 14.26M | 14.41M | 14.59M | 14.79M | 15.33M | 14.52M | ||||||||||||||||||||
| Selling, General & AdministrativeSG&A | 9.57M | 12.87M | 15.91M | 17.86M | 19.93M | 24.03M | 24.04M | 25.90M | 23.70M | 24.65M | 26.06M | 27.63M | 28.67M | 31.29M | 32.65M | 35.07M | 37.58M | 41.45M | 41.01M | 39.85M | ||||||||||||||||||||
| Restructuring CostsRestructuring | 25.00M | 12.50M | 12.50M | 37.50M | 37.50M | 37.50M | 12.50M | |||||||||||||||||||||||||||||||||
| Other Operating ExpensesOther Opex | -12.50M | 100.00M | -22.58M | -18.99M | -37.50M | 5.03M | 7.17M | 4.26M | 6.59M | 6.32M | 6.44M | |||||||||||||||||||||||||||||
| Operating ExpensesOpex | 15.65M | 21.88M | 50.22M | 28.75M | 31.45M | 34.77M | 48.82M | 38.05M | 34.55M | 38.90M | 51.93M | 61.72M | 61.37M | 49.76M | 51.93M | 56.64M | 56.43M | 62.84M | 62.67M | 60.80M | ||||||||||||||||||||
| Operating IncomeOp. Inc | -15.65M | -21.88M | -50.22M | -28.75M | -31.45M | -34.77M | -48.82M | -38.05M | -25.99M | 3.25M | -6.68M | 8.57M | 22.47M | 41.38M | 36.25M | 39.40M | 41.37M | 44.27M | 53.69M | 58.42M | ||||||||||||||||||||
| EBIT | -15.65M | -21.88M | -50.22M | -28.75M | -31.45M | -34.77M | -48.82M | -38.05M | -25.99M | 3.25M | -6.68M | 8.57M | 22.47M | 41.38M | 36.25M | 39.40M | 41.37M | 44.27M | 53.69M | 58.42M | ||||||||||||||||||||
| Non-operating items | ||||||||||||||||||||||||||||||||||||||||
| Non Operating Interest Expenses | ||||||||||||||||||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.01M | -0.15M | -1.03M | -0.35M | 0.07M | 6.53M | 0.57M | -0.08M | 6.74M | 7.41M | -0.88M | -0.25M | 7.30M | 7.24M | 0.34M | 7.38M | 6.59M | 6.86M | -1.58M | 7.66M | ||||||||||||||||||||
| Non Operating IncomeNon Op. Inc. | ||||||||||||||||||||||||||||||||||||||||
| Net income details | ||||||||||||||||||||||||||||||||||||||||
| EBT | -15.64M | -22.02M | -51.26M | -29.10M | -31.38M | -28.24M | -48.25M | -33.21M | 80.75M | 10.66M | 0.93M | 16.05M | 29.77M | 48.61M | 43.60M | 46.77M | 47.97M | 51.13M | 61.44M | 66.08M | ||||||||||||||||||||
| Tax ProvisionsTaxes | 1.97M | 0.48M | 2.60M | 3.10M | 7.90M | 8.44M | -31.40M | -0.26M | 5.51M | 11.31M | ||||||||||||||||||||||||||||||
| Profit After TaxPAT | -15.59M | -21.95M | -49.97M | -28.11M | -29.85M | -31.30M | -45.30M | -33.21M | 80.75M | 9.71M | 0.93M | 15.57M | 29.33M | 44.60M | 35.73M | 39.10M | 79.36M | 51.44M | 55.93M | 54.77M | ||||||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -15.64M | -22.02M | -51.26M | -29.10M | -31.38M | -28.24M | -48.25M | -33.21M | 80.75M | 8.69M | 0.93M | 15.57M | 27.17M | 45.51M | 35.70M | 38.33M | 79.37M | 51.39M | 55.93M | 54.77M | ||||||||||||||||||||
| Consolidated Net IncomeConsol Net Inc. | -15.64M | -22.02M | -51.26M | -29.10M | -31.38M | -28.24M | -48.25M | -33.21M | 80.75M | 8.69M | 0.93M | 15.57M | 27.17M | 45.51M | 35.70M | 38.33M | 79.37M | 51.39M | 55.93M | 54.77M | ||||||||||||||||||||
| Income towards Parent CompanyParent Net Inc | -15.64M | -22.02M | -51.26M | -29.10M | -31.38M | -28.24M | -48.25M | -33.21M | 80.75M | 8.69M | 0.93M | 15.57M | 27.17M | 45.51M | 35.70M | 38.33M | 79.37M | 51.39M | 55.93M | 54.77M | ||||||||||||||||||||
| Net Income towards Common StockholdersNet Income | -15.64M | -22.02M | -51.26M | -29.10M | -31.38M | -28.24M | -48.25M | -33.21M | 80.75M | 8.69M | 0.93M | 15.57M | 27.17M | 45.51M | 35.70M | 38.33M | 79.37M | 51.39M | 55.93M | 54.77M | ||||||||||||||||||||
| Additional items | ||||||||||||||||||||||||||||||||||||||||
| EPS (Basic) | -0.70 | -0.99 | -2.04 | -1.14 | -1.22 | -1.11 | -1.88 | -1.25 | 2.88 | 0.32 | 0.03 | 0.54 | 0.95 | 1.59 | 1.24 | 1.33 | 2.74 | 1.78 | 1.91 | 1.85 | ||||||||||||||||||||
| EPS (Diluted) | -0.70 | -0.99 | -2.04 | -1.14 | -1.22 | -1.11 | -1.88 | -1.25 | 2.79 | 0.31 | 0.03 | 0.53 | 0.91 | 1.53 | 1.20 | 1.29 | 2.66 | 1.72 | 1.83 | 1.79 | ||||||||||||||||||||
| Shares Outstanding | 22.21M | 22.20M | 25.11M | 25.55M | 25.62M | 25.49M | 25.71M | 26.66M | 28.04M | 27.15M | 28.30M | 28.60M | 28.72M | 28.59M | 28.82M | 28.91M | 28.95M | 28.94M | 29.29M | 29.53M | ||||||||||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 22.21M | 22.20M | 25.11M | 25.55M | 25.62M | 25.49M | 25.71M | 26.66M | 28.89M | 27.75M | 29.29M | 29.64M | 29.90M | 29.74M | 29.87M | 29.75M | 29.83M | 29.95M | 30.51M | 30.66M | ||||||||||||||||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 22.24M | 25.21M | 25.64M | 25.66M | 25.71M | 25.76M | 25.80M | 27.97M | 28.19M | 28.24M | 28.53M | 28.71M | 28.76M | 28.79M | 28.90M | 28.93M | 28.98M | 29.19M | 29.44M | 29.60M | ||||||||||||||||||||
| EBITDA | -15.65M | -21.88M | -50.22M | -28.75M | -31.45M | -34.77M | -48.82M | -38.05M | -25.99M | 3.25M | -6.68M | 8.57M | 22.47M | 41.38M | 36.25M | 39.40M | 41.37M | 44.27M | 53.69M | 58.42M | ||||||||||||||||||||
| Interest ExpensesInt Expense | ||||||||||||||||||||||||||||||||||||||||
| Tax Rate | 18.44% | 2.97% | 8.73% | 6.37% | 18.12% | 18.05% | -65.46% | -0.51% | 8.97% | 17.12% |